TIPS in Fundal Variceal Bleeding (the TFB Study)
Launched by INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER · Feb 10, 2015
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients developing acute variceal bleeding from GOV2 and/or IGV1 defined according to Baveno II criteria, admitted in the Hospital and receiving standard combined medical therapy (somatostatin 3 mg/12h continuous IV infusion or terlipressin, 2mg/4h IV + endoscopic injection of tissue adhesives as per center protocol).
- Exclusion Criteria:
- • Hepatocarcinoma without therapeutic options (according to Milan criteria).
- • Portal or mesenteric vein thrombosis avoiding the performance of TIPS.
- • Acute alcoholic hepatitis.
- • Platelet count \< 20.000/mm3.
- • Previous treatment with portosystemic shunt.
- • Pregnancy.
- • Previous inclusion in the current study.
- • Terminal liver disease (bilirrubin \> 10 mg/dL and/or prothrombin index \< 30%); or other fatal non-liver diseases.
- • Denied informed consent.
About Institut D'investigacions Biomèdiques August Pi I Sunyer
The Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a leading biomedical research institute based in Barcelona, Spain, dedicated to advancing scientific knowledge and innovation in health and disease. Affiliated with the University of Barcelona, IDIBAPS fosters a multidisciplinary approach to research, integrating clinical and basic science to enhance understanding of various medical conditions. The institute emphasizes collaboration among researchers, clinicians, and industry partners to translate research findings into effective therapies and improve patient care. With a commitment to excellence, IDIBAPS plays a pivotal role in shaping the future of biomedical science and healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lleida, , Spain
Badalona, Catalonia, Spain
Barcelona, Catalonia, Spain
Barcelona, Catalonia, Spain
Barcelona, Catalonia, Spain
Patients applied
Trial Officials
Angels Escorsell, MD
Principal Investigator
Senior Consultant. Liver Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials